Cargando…

Assessing the level of knowledge and available sources of information about hepatitis C infection among HCV-infected Egyptians

BACKGROUND: Egypt has the largest proportion of hepatitis C virus (HCV) infection worldwide and there is an urgent need to increase community awareness and knowledge about the disease in the country. The main aim of this study was to assess the level of knowledge and awareness about HCV in clinicall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sultan, Noha Yahia, YacoobMayet, Ahmed, Alaqeel, Sinaa Abdulmohsen, Al-Omar, Hussain Abdulrahman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007060/ https://www.ncbi.nlm.nih.gov/pubmed/29914434 http://dx.doi.org/10.1186/s12889-018-5672-6

Ejemplares similares

Analysis of written advertising material distributed through community pharmacies in Riyadh, Saudi Arabia
por: Al-Aqeel, Sinaa AbdulMohsen, et al.
Publicado: (2013)

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
por: Tabll, Ashraf, et al.
Publicado: (2011)

Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients
por: W. ABD EL-WAHAB, Ekram, et al.
Publicado: (2014)

Counselling practices in community pharmacies in Riyadh, Saudi Arabia: a cross-sectional study
por: Alaqeel, Sinaa, et al.
Publicado: (2015)

Assessment of immunological changes in Epstein-Barr virus co-infection in Egyptian chronic HCV patients
por: Shoman, Sahar, et al.
Publicado: (2014)

HCV and HEV: two players in an Egyptian village, a study of prevalence, incidence, and co-infection
por: Elhendawy, Mohammed, et al.
Publicado: (2020)

Evaluation of new cases of HCV infection in thalassaemia patients for source of infection
por: Azarkeivan, Azita, et al.
Publicado: (2011)

Circulating microRNAs as predictors of response to sofosbuvir + daclatasvir + ribavirin in in HCV genotype-4 Egyptian patients
por: Hassuna, Noha Anwar, et al.
Publicado: (2022)

Rivaroxaban prescribing in a Saudi tertiary care teaching hospital
por: Mayet, Ahmed Yacoob, et al.
Publicado: (2018)

Whole Genome 5′-Methylcytosine Level Quantification in Cirrhotic HCV-Infected Egyptian Patients with and without Hepatocellular Carcinoma
por: Awad, Ahmed M., et al.
Publicado: (2020)

Association of HCV with diabetes mellitus: an Egyptian case-control study
por: Elhawary, Eman I, et al.
Publicado: (2011)

Occult HCV Infection: The Current State of Knowledge
por: Rezaee-Zavareh, Mohammad Saeid, et al.
Publicado: (2015)

TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis
por: Nomair, Azhar Mohamed, et al.
Publicado: (2021)

Impact of Apo E gene polymorphism on HCV therapy related outcome in a cohort of HCV Egyptian patients
por: Gomaa, Howayda E., et al.
Publicado: (2018)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

HCV-infected Renal Transplant Recipients: Our Experience before the Availability of New Antiviral Drugs
por: Fernandes, A. R., et al.
Publicado: (2017)

Injection Drug Use Is a Risk Factor for HCV Infection in Urban Egypt
por: Paez Jimenez, Adela, et al.
Publicado: (2009)

Evaluation of Nitric Oxide (NO) Levels in Hepatitis C Virus (HCV) Infection: Relationship to Schistosomiasis and Liver Cirrhosis among Egyptian Patients
por: Hassan, Mahmoud Ismail, et al.
Publicado: (2002)

Diagnostic Accuracy of Acoustic Radiation Force Impulse (ARFI) in Diagnosis of Liver Fibrosis among Egyptian Patients with Chronic HCV Infection
por: Elhosary, Yasser A., et al.
Publicado: (2016)

Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients
por: Mohamed Fteah, Asmaa, et al.
Publicado: (2019)

A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients
por: Omran, Moataza H, et al.
Publicado: (2013)

Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment
por: Amer, Fatma, et al.
Publicado: (2019)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease
por: El-Awady, Mostafa K., et al.
Publicado: (2012)

Knowledge, attitude, and practice regarding child maltreatment among health care providers working in primary care centers in Riyadh, Saudi Arabia
por: Alkathiri, Moath Abdulmohsen, et al.
Publicado: (2021)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

What Egyptians think. Knowledge, attitude, and opinions of Egyptian patients towards biobanking issues
por: Abdelhafiz, Ahmed S., et al.
Publicado: (2019)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients
por: Kushner, Lauren E., et al.
Publicado: (2013)

Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis
por: Abdel-Hafiz, Samah Mamdouh, et al.
Publicado: (2018)

Lipid Metabolism and HCV Infection
por: Targett-Adams, Paul, et al.
Publicado: (2010)

Prevalence of Occult Hepatitis C Virus Infection in Egyptian Patients with Lymphoma: A New Vision
por: Elkashef, Kholoud A., et al.
Publicado: (2022)

Distinct immunoregulatory cytokine pattern in Egyptian patients with occult Hepatitis C infection and unexplained persistently elevated liver transaminases
por: Gad, Yahia Z., et al.
Publicado: (2012)

Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4
por: Zekri, Abdel Rahman N, et al.
Publicado: (2007)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
por: Luxenburger, Hendrik, et al.
Publicado: (2018)

Vaccination status of patients using anti-TNF therapy and the physicians’ behavior shaping the phenomenon: Mixed-methods approach
por: Al-Omar, Hussain Abdulrahman, et al.
Publicado: (2019)

Molecular surveillance of HCV mono-infection and HCV-HBV co-infection in symptomatic population at Hyderabad, Pakistan
por: Patoli, Bushra B, et al.
Publicado: (2018)

Compartmentalization of Resistance-Associated Substitutions in HIV/HCV-Infected Patients: Possible Correlation with Infecting HCV Genotype
por: Morsica, Giulia, et al.
Publicado: (2021)

Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4
por: Rizk, Hanan H., et al.
Publicado: (2016)

Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir
por: Nada, Ali, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_48cr803qu3hj36802u96ob7gi1